The Korean Journal of Medicine

  • 제84권2호
  • /
  • Pages.245-248
  • /
  • 2013
  • /
  • 1738-9364(pISSN)
  • /
  • 2289-0769(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

위장관 출혈로 발견된 신세포암의 늦은 십이지장전이 1예

Late Presentation of Metastatic Renal Cell Carcinoma as a Bleeding Duodenal Mass

  • Seo, Jae Won (Department of Internal Medicine, Seoul Veterans Hospital) ;
  • Kang, Eun Mi (Department of Internal Medicine, Seoul Veterans Hospital) ;
  • Kim, Sung Hoon (Department of Internal Medicine, Seoul Veterans Hospital) ;
  • Jang, Ji Sun (Department of Internal Medicine, Seoul Veterans Hospital) ;
  • Bang, Jei So (Department of Internal Medicine, Seoul Veterans Hospital) ;
  • Yang, Su Hyun (Department of Internal Medicine, Seoul Veterans Hospital) ;
  • Park, Yang Soon (Department of Pathology, Seoul Veterans Hospital)
  • 투고 : 2012.01.06
  • 심사 : 2012.05.30
  • 발행 : 2013.02.01
⟨ 이전 논문 다음 논문 ⟩

초록

저자들은 신세포암으로 우측 근치적 신절제술을 시행하고 22년이라는 긴 시간 동안 무병상태로 지내던 환자에서 위장관 출혈로 발견된 신세포암의 십이지장 단일 전이 증례를 경험하였다. 신세포암으로 신절제술을 시행한 과거력을 가지고 있는 환자들 중 위장관 증상을 보이는 경우 신세포암의 느린 성장속도를 고려하여 내시경 및 영상의학 검사를 통하여 전이성 병변을 확인하는 것이 필요할 것으로 생각된다.

Gastrointestinal metastasis of a renal cell carcinoma is very rare, and the clinical course of the disease ranges from months to several decades. We experienced a case of solitary duodenal metastasis about 22 years after a right nephrectomy for clear-cell type renal cell carcinoma in a 77-year-old man who complained of melena. This case is the longest reported time interval between surgical nephrectomy to presentation with a duodenal metastasis. Patients usually present with recurrence within a year after radical nephrectomy but can present after many years, warranting lifelong surveillance.

키워드

참고문헌

  1. Ritchie AW, deKernion JB. The natural history and clinical features of renal carcinoma. Semin Nephrol 1987;7:131-139.
  2. Lynch-Nyhan A, Fishman EK, Kadir S. Diagnosis and management of massive gastrointestinal bleeding owing to duodenal metastasis from renal cell carcinoma. J Urol 1987; 138:611-613. https://doi.org/10.1016/S0022-5347(17)43275-7
  3. Janzen RM, Ramj AS, Flint JD, Scudamore CH, Yoshida EM. Obscure gastrointestinal bleeding from an ampullary tumour in a patient with a remote history of renal cell carcinoma: a diagnostic conundrum. Can J Gastroenterol 1998;12:75-78. https://doi.org/10.1155/1998/429832
  4. Kradjian RM, Bennington JL. Renal carcinoma recurrent 31 years after nephrectomy. Arch Surg 1965;90:192-195. https://doi.org/10.1001/archsurg.1965.01320080016004
  5. Jung JO, Hong JH, Kim SG, et al. A case of jejunal hemorrahage from metastatic renal cell carcinoma. Korean J Med 2004;67:867-870.
  6. Rustagi T, Rangasamy P, Versland M. Duodenal bleeding from metastatic renal cell carcinoma. Case Rep Gastroenterol 2011;5:249-257. https://doi.org/10.1159/000327996
  7. Hsu CC, Chen JJ, Changchien CS. Endoscopic features of metastatic tumors in the upper gastrointestinal tract. Endoscopy 1996;28:249-253. https://doi.org/10.1055/s-2007-1005437
  8. Bhatia A, Das A, Kumar Y, Kochhar R. Renal cell carcinoma metastasizing to duodenum: a rare occurrence. Diagn Pathol 2006;1:29. https://doi.org/10.1186/1746-1596-1-29
  9. Thyavihally YB, Mahantshetty U, Chamarajanagar RS, Raibhattanavar SG, Tongaonkar HB. Management of renal cell carcinoma with solitary metastasis. World J Surg Oncol 2005;3:48. https://doi.org/10.1186/1477-7819-3-48
  10. Escudier B, Eisen T, Stadler WM, et al. Sorafenib for treatment of renal cell carcinoma: final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. J Clin Oncol 2009;27:3312-3318. https://doi.org/10.1200/JCO.2008.19.5511